tamibarotene has been researched along with Leukemia, Prolymphocytic in 1 studies
*Leukemia, Prolymphocytic: A chronic leukemia characterized by a large number of circulating prolymphocytes. It can arise spontaneously or as a consequence of transformation of CHRONIC LYMPHOCYTIC LEUKEMIA. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, Y; Kagechika, H; Kawachi, E; Shudo, K; Yamakawa, T | 1 |
1 other study(ies) available for tamibarotene and Leukemia, Prolymphocytic
| Article | Year |
|---|---|
Retinobenzoic acids. 5. Retinoidal activities of compounds having a trimethylsilyl or trimethylgermyl group(s) in human promyelocytic leukemia cells HL-60.
Topics: Antineoplastic Agents; Benzoates; Cell Differentiation; Chemical Phenomena; Chemistry; Humans; Leukemia, Prolymphocytic; Organometallic Compounds; Silicon; Structure-Activity Relationship; Trimethylsilyl Compounds; Tumor Cells, Cultured | 1990 |